港股異動 | 福萊特玻璃跌逾3% 遭股東蔣錦志減持34萬股
格隆匯10月16日丨福萊特玻璃(6865.HK)現報3.61港元,跌3.48%,暫成交316.8萬港元,最新總市值70.4億港元。港交所最新權益資料顯示,福萊特玻璃被股東蔣錦志於10月10日在場內以每股平均價3.8424港元減持34萬股,涉資約130.64萬港元。減持後,蔣錦志的最新持股數目為44,961,000股,持股比例由10.07%降至9.99%。此外據悉,福萊特玻璃將於10月24日發佈財報,曾公佈中期股東應占溢利為2.61億元人民幣,同比上升22.8%。交銀國際曾發報告預計今明兩年我國風電新增併網量均將增至25吉瓦,維持福萊特玻璃為首推股,評級“買入”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.